云南白药品牌怎么样 申请店铺

我要投票 云南白药在保健养生行业中的票数:512 更新时间:2025-04-27
云南白药是哪个国家的品牌?「云南白药」是 云南白药集团股份有限公司 旗下著名品牌。该品牌发源于云南省昆明市,由创始人王明辉在1993-11-30期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云南白药品牌出海!通过在本页面挂载云南白药品牌的产品链接和联系方式,可以提高云南白药产品曝光!跨境电商爆单神器,目前只要100元/年哦~

云南白药怎么样

云南白药由云南民间名医曲焕章先生于1902年创制,问世百年来,以其神奇的疗效被世人誉之为“伤科圣药”、“中华瑰宝”。

1971年,公司前身云南白药厂正式成立,白药开始了专业化生产。公司于1993年在深交所挂牌上市,成为云南省第一家A股上市公司。1996年,公司分别投资控股原云南地州的三家云南白药生产企业,即云南大理州制药厂、云南文山州制药厂和云南丽江药业有限公司,共同组成云南白药集团,对云南白药的生产经营实行“五统一”,为名牌战略的实施奠定了基础。1997年公司经国家批准获得自营进出口权。1999年,红塔成为白药集团第二大股东,实现了股权多元化;同年,云南省医药公司和天紫红药厂以优质资产配股方式进入云南白药集团,集团产业链从生产制造延伸到了药品流通和饮片加工领域。目前,省医药公司已成功改组为云南省医药有限公司,在云南首家通过国家GSP认证。天紫红药厂已改制为云南白药集团原生药材事业部,作为省内唯一的饮片加工企业,已于2003年顺利通过国家GMP认证。

经过30多年的发展,公司已从一个资产不足300万元的生产企业成长为一个总资产22亿多,总销售收入逾32亿元,经营涉及化学原料药、化学药制剂、中成药、中药材、生物制品、保健食品、化妆品及饮料的研制、生产及销售;糖、茶,建筑材料,装饰材料的批发、零售、代购代销;科技及经济技术咨询服务,医疗器械(二类、医用敷料类、一次性使用医疗卫生用品),日化用品等领域的云南省实力最强、品牌最优的大型医药企业集团。公司产品以云南白药系列和田七系列为主,共十种剂型七十余个产品,主要销往国内、港澳、东南亚等地区,并已进入日本、欧美等国家、地区的市场。“云南白药”商标于2002年2月被国家工商行政管理总局商标局评为中国驰名商标。

Yunnan Baiyao was created in 1902 by Mr. Qu Huanzhang, a famous folk doctor in Yunnan Province. It has been known as "the holy medicine of Traumatology" and "the treasure of China" for its magical curative effect for more than 100 years. In 1971, Yunnan Baiyao factory, the predecessor of the company, was officially established and specialized production of Baiyao began. The company was listed on Shenzhen Stock Exchange in 1993 and became the first A-share listed company in Yunnan Province. In 1996, the company invested and controlled three Yunnan Baiyao production enterprises in the former Yunnan Prefecture, namely Yunnan Dalizhou pharmaceutical factory, Yunnan Wenshanzhou pharmaceutical factory and Yunnan Lijiang Pharmaceutical Co., Ltd. to jointly form Yunnan Baiyao group, which implemented "Five Unifications" for the production and operation of Yunnan Baiyao, laying a foundation for the implementation of the famous brand strategy. In 1997, the company obtained the right of self import and export with the approval of the state. In 1999, Hongta became the second largest shareholder of Baiyao group, realizing equity diversification; in the same year, Yunnan pharmaceutical company and Tianzi Hongyao factory entered Yunnan Baiyao group by way of high-quality asset allotment, and the industrial chain of the group extended from production and manufacturing to the field of drug circulation and processing of decoction pieces. At present, the provincial pharmaceutical company has been successfully restructured into Yunnan Pharmaceutical Co., Ltd., the first one in Yunnan to pass the national GSP certification. Tianzihong pharmaceutical factory has been transformed into Yunnan Baiyao Group's original medicine business department. As the only processing enterprise in the province, it has successfully passed the national GMP certification in 2003. After more than 30 years of development, the company has grown from a production enterprise with less than 3 million yuan of assets to a total asset of more than 2.2 billion yuan, with a total sales revenue of more than 3.2 billion yuan. Its business involves the research, production and sales of chemical raw materials, chemical pharmaceutical preparations, Chinese patent medicines, biological products, health food, cosmetics and drinks; It is a large pharmaceutical enterprise group with the strongest strength and the best brand in Yunnan Province in the fields of sugar, tea, building materials, decoration materials wholesale, retail, purchasing and selling on behalf of others; scientific and technological and economic and technological consulting services, medical devices (class II, medical dressings, disposable medical and health products), daily chemical products, etc. The company's products are mainly Yunnan Baiyao series and Tianqi series, with a total of more than 70 dosage forms, which are mainly sold to domestic, Hong Kong, Macao, Southeast Asia and other regions, and have entered the markets of Japan, Europe and the United States and other countries and regions. "Yunnan Baiyao" trademark was awarded as China's well-known trademark by the Trademark Office of the State Administration for Industry and Commerce in February 2002.

本文链接: https://brand.waitui.com/7cc1e882e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

视源股份:2024年营收224.01亿元,同比增长11%

36氪获悉,视源股份(002841.SZ)同步披露了2024年年报和2025年一季报,业绩增长稳健。2024年视源股份实现营业收入224.01亿元,同比增长11%,创历史新高;归属于母公司股东的净利润9.71亿元。2024年公司全年海外收入达到43.5亿元,同比增长16.83%。2024年智能控制部件业务营收首次突破100亿元,达102.74亿元,同比增长20.37%。2025年第一季度延续稳健增长态势,公司实现营业收入50.05亿元,同比增长11.35%。同时,视源股份已宣布正式启动港股上市计划。

34分钟前

受特朗普关税影响 IDC预计2025年全球IT支出增长率将从10%降至5%

据日经中文,美国特朗普政府的关税政策正在成为高科技产业的逆风,如果将税率上升部分转嫁到价格上,那么智能手机、个人电脑、服务器等多种产品的需求将下降。调查公司IDC预计,2025年全球IT支出增长率将从同比增长10%降至同比增长5%。此前,IDC预计2025年的IT支出规模为4.1万亿美元,同比增长10%。(财联社)

34分钟前

宝马中国宣布接入DeepSeek

继与阿里巴巴达成AI大语言模型战略合作后,宝马再度深化本土AI生态布局,宝马中国宣布接入DeepSeek。未来,DeepSeek功能也将应用于国产宝马新世代车型。今年三季度开始,将率先应用于多款搭载第9代(BMW)操作系统的中国在售新车,通过深度思考能力赋能以BMW智能个人助理为中心的人机交互体验。(财联社)

34分钟前

“五一”假期民航旅客运输量预计1075万人次 ,创同期历史新高

民航局发布“五一”假期民航运输保障安排。民航局运输司副司长商可佳介绍,“五一”假期是旅游休闲、探亲访友的出行高峰期,民航运输市场将保持平稳增长态势。今年“五一”假期共计5天,根据预测,民航旅客运输量约为1075万人次,日均215万,同比2024年增长8%,创同期历史新高。假期首末的单日客流峰值有望突破230万人次。(中国民航报)

34分钟前

飞天茅台价涨 今日25年飞天原箱批价报2150元/瓶

今日酒价披露的批发参考价显示,4月27日,25年飞天茅台原箱较前一日上涨15元,报2150元/瓶。24年飞天茅台原箱较前一日上涨20元,报2160元/瓶;24年飞天茅台散瓶较前一日上涨10元,报2100元/瓶。(财联社)

34分钟前

本页详细列出关于云南白药的品牌信息,含品牌所属公司介绍,云南白药所处行业的品牌地位及优势。
咨询